Literature DB >> 27324049

Neuroprotective potential of Linezolid: a quantitative and distribution study via mass spectrometry.

Sooraj Baijnath1, Adeola Shobo1, Linda A Bester2, Sanil D Singh2, Gert Kruger1, Per I Arvidsson1,3, Tricia Naicker1, Thavendran Govender4.   

Abstract

A study was undertaken to determine the neuroprotective potential of Linezolid (LIN) in an animal model. Female Sprague-Dawley rats were either given a single (100 mg/kg) dose or treated daily for 4 weeks. A validated LC-MS/MS method was used to measure LIN levels in plasma and brain, this was paired with mass spectrometry imaging to determine the tissue spatial distribution of the drug. The results showed that after a single dose there was poor penetration of the drug into the brain. With multiple doses there were high tissue levels, with the drug reaching steady state in subsequent weeks. LIN displayed a promising distribution pattern with localisation in the brainstem. Systemic circulation is fed into the brain by the carotid and vertebral arteries which enter through the brain stem, therefore high drug concentrations is this area may protect against infectious agents entering via this route.

Entities:  

Keywords:  Brain; LC–MS/MS; Linezolid; MSI; Molecular histology; Neuroprotection

Mesh:

Substances:

Year:  2016        PMID: 27324049     DOI: 10.1007/s10735-016-9685-0

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  23 in total

1.  Pharmacokinetics of intravenous linezolid in cerebrospinal fluid and plasma in neurointensive care patients with staphylococcal ventriculitis associated with external ventricular drains.

Authors:  Ronny Beer; Klaus W Engelhardt; Bettina Pfausler; Gregor Broessner; Raimund Helbok; Peter Lackner; Christian Brenneis; Stefan T Kaehler; Apostolos Georgopoulos; Erich Schmutzhard
Journal:  Antimicrob Agents Chemother       Date:  2006-10-16       Impact factor: 5.191

2.  Visualization of Time-Dependent Distribution of Rifampicin in Rat Brain Using MALDI MSI and Quantitative LCMS/MS.

Authors:  Adeola Shobo; Dominika Bratkowska; Sooraj Baijnath; Suhashni Naiker; Linda A Bester; Sanil D Singh; Glenn Eamond Mitchell Maguire; Hendrik Gert Kruger; Thavendran Govender
Journal:  Assay Drug Dev Technol       Date:  2015-06-12       Impact factor: 1.738

3.  Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients.

Authors:  Pavlos Myrianthefs; Sophia L Markantonis; Konstantinos Vlachos; Maria Anagnostaki; Eleni Boutzouka; Dimitris Panidis; Georgios Baltopoulos
Journal:  Antimicrob Agents Chemother       Date:  2006-09-18       Impact factor: 5.191

4.  Effect of linezolid on the 50% lethal dose and 50% protective dose in treatment of infections by Gram-negative pathogens in naive and immunosuppressed mice and on the efficacy of ciprofloxacin in an acute murine model of septicemia.

Authors:  Andrea Marra; Lucinda Lamb; Ivette Medina; David George; Glenn Gibson; Joel Hardink; Jady Rugg; Jeffrey Van Deusen; John P O'Donnell
Journal:  Antimicrob Agents Chemother       Date:  2012-06-18       Impact factor: 5.191

5.  Linezolid penetration into cerebrospinal fluid and brain tissue.

Authors:  A Tsona; S Metallidis; N Foroglou; P Selviaridis; T Chrysanthidis; G Lazaraki; M Papaioannou; J Nikolaidis; P Nikolaidis
Journal:  J Chemother       Date:  2010-02       Impact factor: 1.714

6.  PET/CT imaging reveals a therapeutic response to oxazolidinones in macaques and humans with tuberculosis.

Authors:  M Teresa Coleman; Ray Y Chen; Myungsun Lee; Philana Ling Lin; Lori E Dodd; Pauline Maiello; Laura E Via; Youngran Kim; Gwendolyn Marriner; Veronique Dartois; Charles Scanga; Christopher Janssen; Jing Wang; Edwin Klein; Sang Nae Cho; Clifton E Barry; JoAnne L Flynn
Journal:  Sci Transl Med       Date:  2014-12-03       Impact factor: 17.956

7.  MALDI MSI and LC-MS/MS: Towards preclinical determination of the neurotoxic potential of fluoroquinolones.

Authors:  Adeola Shobo; Sooraj Baijnath; Dominika Bratkowska; Suhashni Naiker; Anou M Somboro; Linda A Bester; Sanil D Singh; Tricia Naicker; Hendrik G Kruger; Thavendran Govender
Journal:  Drug Test Anal       Date:  2015-09-18       Impact factor: 3.345

8.  Design, Synthesis, and Identification of Silicon Incorporated Oxazolidinone Antibiotics with Improved Brain Exposure.

Authors:  B Seetharamsingh; Remya Ramesh; Santoshkumar S Dange; Pankaj V Khairnar; Smita Singhal; Dilip Upadhyay; Sridhar Veeraraghavan; Srikant Viswanadha; Swaroop Vakkalanka; D Srinivasa Reddy
Journal:  ACS Med Chem Lett       Date:  2015-10-26       Impact factor: 4.345

9.  Linezolid in the treatment of multidrug-resistant tuberculosis.

Authors:  G F Schecter; C Scott; L True; A Raftery; J Flood; S Mase
Journal:  Clin Infect Dis       Date:  2010-01-01       Impact factor: 9.079

10.  Clinical update on linezolid in the treatment of Gram-positive bacterial infections.

Authors:  Sally Ager; Kate Gould
Journal:  Infect Drug Resist       Date:  2012-06-25       Impact factor: 4.003

View more
  3 in total

1.  Post heroin dose tissue distribution of 6-monoacetylmorphine (6-MAM) with MALDI imaging.

Authors:  Belin G Teklezgi; Annapurna Pamreddy; Sooraj Baijnath; Nirmala D Gopal; Tricia Naicker; Hendrik G Kruger; Thavendran Govender
Journal:  J Mol Histol       Date:  2017-05-26       Impact factor: 2.611

2.  Plasma and Intrapulmonary Pharmacokinetics, and Dosage Regimen Optimization of Linezolid for Treatment of Gram-Positive Cocci Infections in Patients with Pulmonary Infection After Cerebral Hemorrhage.

Authors:  Yongli Wei; He Zhang; Maowu Fu; Rui Ma; Ronghui Li; Lingti Kong
Journal:  Infect Drug Resist       Date:  2022-04-08       Impact factor: 4.003

3.  Bedaquiline has potential for targeting tuberculosis reservoirs in the central nervous system.

Authors:  Annapurna Pamreddy; Sooraj Baijnath; Tricia Naicker; Sphamandla Ntshangase; Sipho Mdanda; Hlengekile Lubanyana; Hendrik G Kruger; Thavendran Govender
Journal:  RSC Adv       Date:  2018-03-28       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.